Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, DuPont HL.

Lancet Infect Dis. 2014 Mar;14(3):197-204. doi: 10.1016/S1473-3099(13)70297-4. Epub 2013 Nov 29.

PMID:
24291168
[PubMed - indexed for MEDLINE]
2.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Meléndez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM.

Lancet. 2008 Jun 14;371(9629):2019-25. doi: 10.1016/S0140-6736(08)60839-9.

PMID:
18554712
[PubMed - indexed for MEDLINE]
3.

Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, Kärnell A, Nyquist I, Svennerholm AM.

Vaccine. 2007 May 30;25(22):4392-400. Epub 2007 Apr 4.

PMID:
17448578
[PubMed - indexed for MEDLINE]
4.

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

McKenzie R, Bourgeois AL, Frech SA, Flyer DC, Bloom A, Kazempour K, Glenn GM.

Vaccine. 2007 May 4;25(18):3684-91. Epub 2007 Jan 23.

PMID:
17313998
[PubMed - indexed for MEDLINE]
5.

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.

Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F.

Cochrane Database Syst Rev. 2013 Jul 5;7:CD009029. doi: 10.1002/14651858.CD009029.pub2. Review.

PMID:
23828581
[PubMed - indexed for MEDLINE]
6.

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG.

Vaccine. 2005 Oct 17;23(43):5120-6.

PMID:
15982790
[PubMed - indexed for MEDLINE]
7.

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.

Glenn GM, Villar CP, Flyer DC, Bourgeois AL, McKenzie R, Lavker RM, Frech SA.

Infect Immun. 2007 May;75(5):2163-70. Epub 2007 Jan 29.

PMID:
17261601
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.

Zanger P, Nurjadi D, Gabor J, Gaile M, Kremsner PG.

Lancet Infect Dis. 2013 Nov;13(11):946-54. doi: 10.1016/S1473-3099(13)70221-4. Epub 2013 Sep 4.

PMID:
24012319
[PubMed - indexed for MEDLINE]
9.

Efficacy of a travelers' diarrhea vaccine system in travelers to India.

Steffen R, Cramer JP, Burchard G, Jelinek T, Schwarz U, Ramdas P, Chatterjee S, Jiang ZD, DuPont HL, Dewasthaly S, Westritschnig K, Behrens RH.

J Travel Med. 2013 Nov-Dec;20(6):374-9. doi: 10.1111/jtm.12064. Epub 2013 Aug 26.

PMID:
24165382
[PubMed - indexed for MEDLINE]
10.

Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea.

Paschke C, Apelt N, Fleischmann E, Perona P, Walentiny C, Löscher T, Herbinger KH.

Clin Microbiol Infect. 2011 Aug;17(8):1194-200. doi: 10.1111/j.1469-0691.2010.03414.x. Epub 2010 Dec 13.

PMID:
21054662
[PubMed - indexed for MEDLINE]
11.

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Güereña-Burgueño F, Hall ER, Taylor DN, Cassels FJ, Scott DA, Wolf MK, Roberts ZJ, Nesterova GV, Alving CR, Glenn GM.

Infect Immun. 2002 Apr;70(4):1874-80.

PMID:
11895950
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.
14.

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM.

Vaccine. 2013 May 7;31(20):2457-64. doi: 10.1016/j.vaccine.2013.03.027. Epub 2013 Mar 27.

PMID:
23541621
[PubMed - indexed for MEDLINE]
Free Article
15.

Protection of piglets against enteric colibacillosis by intranasal immunization with K88ac (F4ac) fimbriae and heat labile enterotoxin of Escherichia coli.

Lin J, Mateo KS, Zhao M, Erickson AK, Garcia N, He D, Moxley RA, Francis DH.

Vet Microbiol. 2013 Mar 23;162(2-4):731-9. doi: 10.1016/j.vetmic.2012.09.025. Epub 2012 Oct 3.

PMID:
23089483
[PubMed - indexed for MEDLINE]
16.

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.

Yu J, Cassels F, Scharton-Kersten T, Hammond SA, Hartman A, Angov E, Corthésy B, Alving C, Glenn G.

Infect Immun. 2002 Mar;70(3):1056-68.

PMID:
11854183
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.

Lapa JA, Sincock SA, Ananthakrishnan M, Porter CK, Cassels FJ, Brinkley C, Hall ER, van Hamont J, Gramling JD, Carpenter CM, Baqar S, Tribble DR.

Clin Vaccine Immunol. 2008 Aug;15(8):1222-8. doi: 10.1128/CVI.00491-07. Epub 2008 Jun 25.

PMID:
18579693
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.

Lundgren A, Leach S, Tobias J, Carlin N, Gustafsson B, Jertborn M, Bourgeois L, Walker R, Holmgren J, Svennerholm AM.

Vaccine. 2013 Feb 6;31(8):1163-70. doi: 10.1016/j.vaccine.2012.12.063. Epub 2013 Jan 7.

PMID:
23306362
[PubMed - indexed for MEDLINE]
19.

Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.

El-Kamary SS, Cohen MB, Bourgeois AL, Van De Verg L, Bauers N, Reymann M, Pasetti MF, Chen WH.

Clin Vaccine Immunol. 2013 Nov;20(11):1764-70. doi: 10.1128/CVI.00464-13. Epub 2013 Sep 18. Erratum in: Clin Vaccine Immunol. 2014 Apr;21(4):602.

PMID:
24049109
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.

López-Gigosos R, García-Fortea P, Reina-Doña E, Plaza-Martín E.

Travel Med Infect Dis. 2007 Nov;5(6):380-4. Epub 2007 Jul 30.

PMID:
17983977
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk